Annual report pursuant to Section 13 and 15(d)

Business (Details)

v3.8.0.1
Business (Details)
1 Months Ended 3 Months Ended 12 Months Ended
Feb. 16, 2018
USD ($)
Aug. 14, 2017
USD ($)
Aug. 31, 2017
USD ($)
Dec. 31, 2017
USD ($)
Sep. 30, 2017
USD ($)
Jun. 30, 2017
USD ($)
Mar. 31, 2017
USD ($)
Dec. 31, 2016
USD ($)
Sep. 30, 2016
USD ($)
Jun. 30, 2016
USD ($)
Mar. 31, 2016
USD ($)
Dec. 31, 2017
USD ($)
product
Dec. 31, 2016
USD ($)
Dec. 31, 2015
USD ($)
Feb. 12, 2018
USD ($)
Dec. 31, 2014
USD ($)
Organization, Consolidation and Presentation of Financial Statements [Abstract]                                
Number of products in development | product                       3        
License and other revenue   $ 25,000,000 $ 25,000,000 $ 0 $ 25,000,000 $ 0 $ 0         $ 25,000,000 $ 0 $ 0    
Escrowed cash receivable   $ 3,750,000 $ 3,750,000 3,752,390       $ 0       3,752,390 0      
Escrow period   12 months 12 months                          
Potential future regulatory milestone payment     $ 20,000,000                          
Subsequent Event [Line Items]                                
Net income (loss)       (3,091,000) $ 18,721,000 $ (1,799,000) $ (1,961,000) (1,639,000) $ (6,169,000) $ (3,524,000) $ (5,140,000) 11,869,823 (16,471,603) (10,490,103)    
Cash flows from operations                       12,519,405 (14,573,138) (10,163,380)    
Accumulated deficit       (58,165,260)       (70,035,083)       (58,165,260) (70,035,083)      
Cash and cash equivalents       $ 2,472,187       $ 5,127,958       $ 2,472,187 $ 5,127,958 $ 21,161,967   $ 11,742,349
Avadel | Subsequent Event                                
Subsequent Event [Line Items]                                
Long-term debt acquired $ 15,000,000                           $ 15,000,000  
Product royalty 15.00%